Replies to post #3050 on Sons and Daughters of BBCMF , Dow 30 With Point an

[mick]

Amgen announces Vectibix receives "positive" opinion for marketing authorization in the European Union (AMGN) 55.80 +0.49 : Co announces that the European Committee for Medicinal Products for Human Use has issued a "positive" opinion recommending a conditional marketing authorization for Vectibix in the European Union for patients with refractory metastatic colorectal cancer with non-mutated KRAS genes.